T1	CHEM 14 60	factor estimulador de colonias de granulocitos
#1	AnnotatorNotes T1	C0079459; Granulocyte Colony-Stimulating Factor; Amino Acid, Peptide, or Protein · Immunologic Factor
T2	ANAT 48 60	granulocitos
#2	AnnotatorNotes T2	C0018183; granulocyte; Cell
T3	DISO 85 103	neutropenia febril
#3	AnnotatorNotes T3	C0746883; Febrile Neutropenia; Disease or Syndrome
T4	DISO 132 138	cáncer
#4	AnnotatorNotes T4	C0006826; Malignant Neoplasms; Neoplastic Process
T5	DISO 143 161	neutropenia febril
#5	AnnotatorNotes T5	C0746883; Febrile Neutropenia; Disease or Syndrome
T6	DISO 163 165	NF
#6	AnnotatorNotes T6	C0746883; Febrile Neutropenia; Disease or Syndrome
T7	PROC 180 193	quimioterapia
#7	AnnotatorNotes T7	C0392920; Chemotherapy Regimen; Therapeutic or Preventive Procedure + C3665472; Chemotherapy; Therapeutic or Preventive Procedure
T8	CHEM 294 340	factor estimulante de colonias de granulocitos
#8	AnnotatorNotes T8	C0079459; Granulocyte Colony-Stimulating Factor; Amino Acid, Peptide, or Protein · Immunologic Factor
T9	ANAT 328 340	granulocitos
#9	AnnotatorNotes T9	C0018183; granulocyte; Cell
T10	PROC 370 383	quimioterapia
#10	AnnotatorNotes T10	C0392920; Chemotherapy Regimen; Therapeutic or Preventive Procedure + C3665472; Chemotherapy; Therapeutic or Preventive Procedure
T11	DISO 423 449	complicaciones infecciosas
#11	AnnotatorNotes T11	C0940933; infection as a complication; Disease or Syndrome
T12	PROC 576 596	En forma randomizada
#12	AnnotatorNotes T12	C0034656; Randomization; Research Activity
T13	PROC 639 665	tratamiento antimicrobiano
#13	AnnotatorNotes T13	C0338237; Antibiotic therapy; Therapeutic or Preventive Procedure
T14	PROC 858 873	hospitalización
#14	AnnotatorNotes T14	C0019993; Hospitalization; Health Care Activity
T15	PROC 925 951	tratamiento antimicrobiano
#15	AnnotatorNotes T15	C0338237; Antibiotic therapy; Therapeutic or Preventive Procedure
T16	DISO 982 988	fiebre
#16	AnnotatorNotes T16	C0015967; Fever; Sign or Symptom
T17	PROC 1082 1107	revisión de la literatura
#17	AnnotatorNotes T17	C3646434; Review of professional literature; Therapeutic or Preventive Procedure
T18	CHEM 62 67	G-CSF
#18	AnnotatorNotes T18	C0079459; Granulocyte Colony-Stimulating Factor; Amino Acid, Peptide, or Protein · Immunologic Factor
T19	CHEM 342 347	G-CSF
#19	AnnotatorNotes T19	C0079459; Granulocyte Colony-Stimulating Factor; Amino Acid, Peptide, or Protein · Immunologic Factor
T20	DISO 504 506	NF
#20	AnnotatorNotes T20	C0746883; Febrile Neutropenia; Disease or Syndrome
T21	DISO 556 558	NF
#21	AnnotatorNotes T21	C0746883; Febrile Neutropenia; Disease or Syndrome
T22	CHEM 621 626	G-CSF
#22	AnnotatorNotes T22	C0079459; Granulocyte Colony-Stimulating Factor; Amino Acid, Peptide, or Protein · Immunologic Factor
T23	CHEM 651 665	antimicrobiano
#23	AnnotatorNotes T23	C0003204; Anti-Infective Agents; Pharmacologic Substance
T24	CHEM 937 951	antimicrobiano
#24	AnnotatorNotes T24	C0003204; Anti-Infective Agents; Pharmacologic Substance
T25	DISO 1029 1040	neutropenia
#25	AnnotatorNotes T25	C0027947; Neutropenia; Disease or Syndrome | C0853697; Neutrophil count decreased; Finding
T26	CHEM 1153 1158	G-CSF
#26	AnnotatorNotes T26	C0079459; Granulocyte Colony-Stimulating Factor; Amino Acid, Peptide, or Protein · Immunologic Factor
T27	DISO 1237 1239	NF
#27	AnnotatorNotes T27	C0746883; Febrile Neutropenia; Disease or Syndrome
T29	LIVB 122 127	niños
#28	AnnotatorNotes T29	C0008059; Child; Age Group
T30	LIVB 248 281	pacientes oncológicos pediátricos
#29	AnnotatorNotes T30	C1516213; Cancer Patient; Patient or Disabled Group + C0008059; Child; Age Group
T31	LIVB 600 609	pacientes
#30	AnnotatorNotes T31	C0030705; Patients; Patient or Disabled Group
T34	Duration 892 898	8 días
T35	Duration 910 916	7 días
T37	Duration 967 973	7 días
T38	Duration 1004 1010	3 días
T39	Duration 1056 1062	4 días
T41	LIVB 1198 1219	pacientes oncológicos
#31	AnnotatorNotes T41	C1516213; Cancer Patient; Patient or Disabled Group
T28	Duration 962 963	8
T32	Duration 999 1000	2
T33	Duration 1051 1052	3
A1	Population_data T29 Age
A2	Population_data T30 Age
T36	Neg_cue 1159 1161	no
T40	Quantifier_or_Qualifier 1170 1181	recomendado
A3	Assertion T40 Negated
#32	AnnotatorNotes T40	C0034866; Recommendation; Idea or Concept
R1	Negation Arg1:T36 Arg2:T40	
T42	CONC 798 809	diferencias
A4	Assertion T42 Negated
#33	AnnotatorNotes T42	C1705241; Delta (difference); Quantitative Concept
T43	Neg_cue 783 785	No
R2	Negation Arg1:T43 Arg2:T42	
T44	Observation 107 118	alto riesgo
#34	AnnotatorNotes T44	C4319571; High risk; Finding
R3	Has_Quantifier_or_Qualifier Arg1:T3 Arg2:T44	
R4	Overlap Arg1:T3 Arg2:T4	
R5	Experiences Arg1:T29 Arg2:T4	
R6	Experiences Arg1:T29 Arg2:T3	
R7	Experiences Arg1:T29 Arg2:T44	
R8	Experiences Arg1:T29 Arg2:T1	
R9	Experiences Arg1:T29 Arg2:T18	
R10	Causes Arg1:T7 Arg2:T6	
R11	Causes Arg1:T7 Arg2:T5	
R12	Experiences Arg1:T30 Arg2:T5	
R13	Experiences Arg1:T30 Arg2:T6	
R14	Experiences Arg1:T30 Arg2:T7	
T45	Observation 217 227	morbilidad
#35	AnnotatorNotes T45	C0026538; Morbidity - disease rate; Finding
R15	Experiences Arg1:T30 Arg2:T45	
T46	CONC 230 240	mortalidad
#36	AnnotatorNotes T46	C0026565; Mortality Vital Statistics; Quantitative Concept
R16	After Arg1:T8 Arg2:T10	
R17	After Arg1:T19 Arg2:T10	
T47	Quantifier_or_Qualifier 384 391	intensa
#37	AnnotatorNotes T47	C0522510; With intensity; Qualitative Concept
R18	Has_Quantifier_or_Qualifier Arg1:T10 Arg2:T47	
R21	Overlap Arg1:T10 Arg2:T11	
R22	Overlap Arg1:T10 Arg2:T20	
T49	Observation 562 573	alto riesgo
#39	AnnotatorNotes T49	C4319571; High risk; Finding
R23	Has_Quantifier_or_Qualifier Arg1:T21 Arg2:T49	
R24	Experiences Arg1:T31 Arg2:T22	
R25	Combined_with Arg1:T22 Arg2:T13	
R26	Used_for Arg1:T23 Arg2:T13	
R27	Before Arg1:T12 Arg2:T22	
T50	CONC 738 770	parámetros biomédicos y clínicos
R28	Has_Duration_or_Interval Arg1:T14 Arg2:T34	
R29	Has_Duration_or_Interval Arg1:T14 Arg2:T35	
R30	Used_for Arg1:T24 Arg2:T15	
R31	Has_Duration_or_Interval Arg1:T15 Arg2:T28	
R32	Has_Duration_or_Interval Arg1:T15 Arg2:T37	
R33	Has_Duration_or_Interval Arg1:T16 Arg2:T32	
R34	Has_Duration_or_Interval Arg1:T16 Arg2:T38	
R35	Has_Duration_or_Interval Arg1:T25 Arg2:T33	
R36	Has_Duration_or_Interval Arg1:T25 Arg2:T39	
R37	Has_Quantifier_or_Qualifier Arg1:T26 Arg2:T40	
R38	Experiences Arg1:T41 Arg2:T26	
R39	Experiences Arg1:T41 Arg2:T27	
R40	Overlap Arg1:T14 Arg2:T15	
T51	Quantifier_or_Qualifier 810 824	significativas
A5	Assertion T51 Negated
#40	AnnotatorNotes T51	C0750502; Significant; Idea or Concept
R43	Has_Quantifier_or_Qualifier Arg1:T42 Arg2:T51	
R44	Negation Arg1:T43 Arg2:T51	
R19	Causes Arg1:T5 Arg2:T45	
R20	Causes Arg1:T6 Arg2:T45	
A6	Experiencer T29 Patient
A7	Experiencer T30 Patient
A8	Experiencer T31 Patient
A9	Experiencer T41 Patient
